AstraZeneca will today, in the presence of His Royal Highness The Prince of Wales, formally unveil The Discovery Centre in Cambridge.
The state-of-the-art research and development (R&D) facility has been designed to the world’s highest environmental standards and accommodates over 2,200 research scientists.
The new £1bn facility will include the most advanced robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and development of next generation therapeutics, including nucleotide-based, gene-editing and cell therapies.
During the unveiling today, His Royal Highness will meet the Chief Executive, the Chairman, Leif Johansson, and other senior leaders, to undertake a walking tour of the new facility and make a short address to invited guests.